U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that the Slinky toy was the result of a failed attempt by engineer Richard James to produce an antivibration device for ship instruments? His goal was to develop a spring that would instantaneously counterbalance the wave motion that rocks a ship at sea. Instead, he developed the Slinky.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/161 - Having -C(=X)-, wherein X is chalcogen, bonded directly to the carbocyclic ring


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein a group, in which X is chalcogen (i.e.,
No. of patents: 62
Last issue date: 10/28/2008


1    
NumberTitleIssue Date
7442793Peptide deformylase inhibitors
Novel PDF inhibitors and novel methods for their use are provided. ...
10/28/2008
72447316-Methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
The present invention relates to 6-methylpyridine derivatives useful as an antiviral agent. More particularly, the present invention relates to novel 6-methylpyridine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus (HCV), or pha...
07/17/2007
72269422-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and related conditions (such as hyperglycemia...
06/05/2007
7223761Salts and polymorphs of a potent antidiabetic compound
Salts and polymorphs of a compound useful in the treatment of inflammatory and metabolic conditions and diseases are provided herein. In particular, the invention provides salts and polymorphs of a compound which modulates the expression and/or function of a peroxis...
05/29/2007
7217714CCR5 modulators
Compounds of Formula 1 [Region α]−[Region β]−[Region γ]−[Region δ]   (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and m...
05/15/2007
7153865N-type calcium channel antagonists for the treatment of pain
Compounds useful for the treatment of pain in accord with the following structural diagram, wherein A, R1, b, R3, d, R4, R5, R6 and R7 are any of ...
12/26/2006
7087758Quinoline inhibitors of hyaki and hyak3 kinases
This invention relates to novel quinoline inhibitors of hYAK1 and hYAK3 kinases and pharmaceutically acceptable salts, hydrates or solvates thereof, pharmaceutical compositions thereof, and methods of treatment of diseases in which an excessive amount of either such...
08/08/2006
69893922-Aminoquinolines as melanin concentrating hormone receptor antagonists
The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, which antagonize the effects of melanin-concentrating hormone (MCH) through the melanin concentrating ...
01/24/2006
6969723Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
Compounds of general formula (I), wherein R4 and R5 stand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched C1-4 alkyl group, straight or ...
11/29/2005
6841680N-type calcium channel antagonists for the treatment of pain
Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are a varie...
01/11/2005
6770648Compounds for the modulation of PPARγ activity
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. ...
08/03/2004
6432962Benzophenones as inhibitors of IL-1ଲ and TNF-଱
Heteroaryl aminobenzophenones of general formula I inhibit interleukin-1ଲ and TNF-଱ and may therefore be useful in the therapy of inflammatory diseases and conditions....
08/13/2002
63690532-Aminoquinolinecarboxamides: neurokinin receptor ligands
Disclosed are compounds of the formula: ##STR1## or pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, wherein R1, R2, R3, X, Q1 and Q2 are defined herein, which compou...
04/09/2002
63102118-hydroxy-7-substituted quinolines as anti-viral agents
The present invention provides for 8-hydroxy-7-substituted quinoline compounds such as formula IA ##STR1## These compounds are useful as anti-viral agents. Specifically, these compounds have anti-viral activity against the herpes virus, cytomegalovir...
10/30/2001
6002008Substituted 3-cyano quinolines
This invention provides compounds having the formula: ##STR1## wherein: X is cycloalkyl which may be optionally substituted; or is a pyridinyl, pyrimidinyl, or phenyl ring; wherein the pyridinyl, pyrimidinyl, or phenyl ring may be optionally substitu...
12/14/1999
5998437Benzimidazole derivatives
The present invention provides novel benzimidazole derivatives or salts thereof represented by the general formula, ##STR1## wherein R1 is a hydrogen atom or a halogen atom; R2 is a phenyl-lower alkyl group; R3 is a h...
12/07/1999
5889021Active Compounds
The present invention relates to novel quinoline derivatives of the formula ##STR1## which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory dis...
03/30/1999
5658933Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
The invention relates to compounds of the formula I, ##STR1## to a process for their preparation and to their use as pharmaceuticals. The compounds are employed, in particular, as ester prodrugs of prolyl hydroxylase inhibitors for inhibiting collage...
08/19/1997
5605909Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds
The compounds of formula I are smooth muscle relaxants: ##STR1## wherein R1 is hydrogen, alkyl, cycloalkyl, alkanoyl, alkylsulfonyl, aroyl, arylalkenoyl, arylsulfonyl, arylalkanoyl or arylalkylsulfonyl; R2 is hydrogen, alkyl or ...
02/25/1997
5565408Cyanoquinoline compounds
Cyanoquinoline compounds Ia or Ib ##STR1## where R1 is CH.dbd.C(CN)2 ; CH.dbd.N--N.dbd.CH--(5-quinolyl); methylsulfonyl; CH.dbd.NOH; halogen; hydroxyl; nitro; cyano; unsubstituted or substituted C1 -C4 -alk...
10/15/1996
5561143Aliphatic amino bis-aryl squalene synthase inhibitors
This invention relates to a class of novel aliphatic amino bis-aryl compounds containing at least four carbon atoms and an amino group either substituted thereon or incorporated therein and is further linked or bridged to two mono- and/or bicyclic rings. ...
10/01/1996
5556863Compound for gastric acid secretion inhibition
The present invention relates to novel quinoline derivatives of the formula ##STR1## which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory dis...
09/17/1996
53569031-cyclopropyl-4-pyridyl-quinolines
Compounds of formula ##STR1## wherein; R1 is hydrogen, lower-alkyl, or trifluoromethyl; R2 is lower-alkyl, trifluoromethyl or CH2 X where X is hydroxy, chloro, lower-alkylamino or dilower-alkylamino; R3 and R
10/18/1994
5223517Heterocyclically substituted cycloalkano[b]-indolesulphonamides
Heterocyclically substituted cycloalkano[b]-indolesulphonamides can be prepared by reaction of appropriate N-unsubstituted indoles with acrylonitrile, followed by hydrolysis, esterification or amidation, or by reaction of heterocyclically substituted hydr...
06/29/1993
5216165N-substituted aminoquinolines as analgesic agents
There are disclosed compounds of the formula ##STR1## wherein R is hydrogen, halo or trifluoromethyl; R1 is hydrogen or X; R2 is hydrogen or X; with the proviso that when R1 is X, R2 is hydrogen, and when R...
06/01/1993
5215999Quinoline derivative and antiulcer agent containing said quinoline derivative
The present invention discloses a quinoline derivative and salt thereof of the following general formula: ##STR1## (wherein R1, R2, R3, R4 and n have the same meanings as defined above). Such a derivative i...
06/01/1993
5143920Substituted 4-aminoquinoline derivatives as gastric secretion inhibitors
Substituted 4-aminoquinazoline derivatives of the formula: ##STR1## wherein R1 is hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl C
09/01/1992
5112837Quinoline derivatives having anti-tumor activity
The invention relates to a quinoline of the formula: ##STR1## wherein each of R1 and R2, which may be the same or different, is hydrogen, halogeno, hydroxy, cyano, carbamoyl, nitro or amino, alkyl, alkoxy, alkylthio, alkylamino,...
05/12/1992
5089504Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
Substituted 4-aminoquinazoline derivatives of the formula: ##STR1## in which R1 is hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxyC1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkylC
02/18/1992
5089498Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
Substituted 4-aminiquinazoline derivatives of the formula: ##STR1## in which R1 hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxyC1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkylC1-...
02/18/1992
5082848Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors
Substituted 4-aminoquinoline derivatives of the formula: ##STR1## wherein R1 is hydrogen, C1-6 alkyl, C1-6 alkoxyC1-6 alkyl; C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, phenyl ...
01/21/1992
50828413-carbonyl-4-amino-8-substituted quinoline compounds useful in inhibiting gastric acid secretions.
Aminoquinoline derivatives are described as inhibitors of the H+ K+ ATPase enzyme useful in the treatment of gastric acidity. A compound of the invention is 3-butyryl-4-(2-methylphenylamino)-8-(3-dimethylaminopropoxy)quinoline....
01/21/1992
5008276Methyl ଱-(2-substituted)pyrid-3-yl-ଲ-methoxyacrylates, compositions containing them and their use as fungicides
Fungicidal compounds of the formula (I): ##STR1## and stereoisomers thereof, wherein K is oxygen or sulphur; Z is optionally substituted aryl or optionally substituted heteroaryl; X is O, S(O)n, NR4, CR1 R2...
04/16/1991
48065504-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid secretion
This invention relates to novel substituted 4-aminoquinoline derivatives which are inhibitors of gastric acid secretion in mammals. A compound of the invention is 3-butyryl-4-(2-methylphenylamino)-8-methoxyquinoline....
02/21/1989
48065494-amino-3-carbonyl substituted quinolines
This invention relates to novel substituted 4-aminoquinoline derivatives which are inhibitors of gastric acid secretion in mammals. A compound of the invention is 3-butyryl-4-(2-methylphenylamino)-8-methoxyquinoline....
02/21/1989
4789677N-alkyl-[N-[N-alkyl-N-[4-(4-quinolinylamino)benzoyl]ami no]alkyl]benzenesulphonamides
New compounds having the formula I ##STR1## where one of A and B is CH or N, the other of A and B is CH, Q is lower alkylene, R is lower alkyl, X1 is halogen or trifluoromethyl and X2 and X3 are independently selected...
12/06/1988
4769461Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
There are disclosed compounds of the formula ##STR1## wherein W represents a covalent bond or ##STR2## X is N or CR2 ; Y is O, S, NR2 or C(R2)2 when n=0, or N or CR2 when n=1 Z is ##STR...
09/06/1988
47677672-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities
2-amino-benzoic acid derivatives, method for making the same as well as its use for therapeutical purposes are proposed. The general formula of 2-amino-benzoic acid derivatives is ##STR1## wherein R represents chlorine or trifluoromethyl, R' is of ge...
08/30/1988
4735952Arylthio piperidinamide of (4-quinolinylamino)benzoic acid and S-oxidized derivatives
This invention provides a piperidine compound of the formula: ##STR1## wherein R1 is hydrogen or trihalomethyl, R2 is hydrogen or protected carboxy, R3 is heterocyclic group or aryl which may be halogen substituted, and X is --...
04/05/1988
4686220Substituted 2-[b-substituted-amino)-ethylamino]-1,4-naphthalenediones for treating asthma, allergic diseases and inflammation in warm-blooded animals
This disclosure describes certain substituted piperazine-1,4-naphthalenediones useful as anti-asthmatic agents....
08/11/1987
1    
 
Sign InRegister
Username  
Password   
forgot password?